- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Adalimumab antibody from different biosimilar commercial drugs.
Showing all 7 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Amgevita® |
50 mg/mL |
– |
2 mg |
-80°C |
12/2021 |
265,50 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hulio® |
50 mg/mL |
– |
2 mg |
-80°C |
02/2023 |
265,50 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
100 mg/mL |
– |
2 mg |
-80°C |
10/2023 |
344,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
100 mg/mL |
– |
4 mg |
-80°C |
02/2024 |
344,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Idacio® |
50 mg/mL |
– |
2 mg |
-80°C |
10/2023 |
345,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Imraldi® |
50 mg/mL |
– |
2 mg |
-80 °C |
10/2023 |
295,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hyrimoz® |
50 mg/mL |
– |
2 mg |
-80°C |
06/2024 |
295,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin